- Fraudulent Email Warning（27KB）
News Release
- August 4, 2026
- NIPRO Introduces Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance (318KB)
Announcement of Spryte Medical, a US Affiliate of NIPRO, Completion of Subject Enrollment in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment (270KB) - July 30, 2026
- NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States (195KB)
- July 29, 2026
- Notice Concerning Expected Recording of Extraordinary Income from Sale of Investment Securities (107KB)
IR News
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
